Literature DB >> 20161171

Synthesis of the northern sector (C8-C19) of rapamycin via Chan rearrangement and oxidation of an alpha-acyloxyacetate.

James D White1, Scott C Jeffrey.   

Abstract

Two routes to the masked tricarbonyl segment of the immunosuppressant rapamycin comprising C8-C19 were explored beginning from D-xylose. The first approach employed a protected form of 2,4,5-trihydroxypentanol to obtain dithiane 43, which failed to react with dimethyl oxalate to give a 1,2,3-tricarbonyl unit corresponding to the northern sector of rapamycin. A second approach employing carboxylic acid 61 derived from 43 utilized base-mediated (Chan) rearrangement of alpha-acyloxyacetate 62 with trapping of the resultant enediolate as bis silyl ether 63. Epoxidation of this diene afforded masked tri-keto ester 65 which underwent acid-catalyzed methanolysis to produce cyclic ketal 67.

Entities:  

Year:  2009        PMID: 20161171      PMCID: PMC2722752          DOI: 10.1016/j.tet.2009.06.026

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  10 in total

1.  Synthesis of the Tricarbonyl Subunit (C(8)-C(19)) of Rapamycin via Tandem Chan Rearrangement-Oxidation.

Authors:  James D. White; Scott C. Jeffrey
Journal:  J Org Chem       Date:  1996-04-19       Impact factor: 4.354

2.  Total synthesis of spongistatin 1: a synthetic strategy exploiting its latent pseudo-symmetry.

Authors:  Matthew Ball; Matthew J Gaunt; David F Hook; Alan S Jessiman; Shigeru Kawahara; Paolo Orsini; Alessandra Scolaro; Adam C Talbot; Huw R Tanner; Shigeo Yamanoi; Steven V Ley
Journal:  Angew Chem Int Ed Engl       Date:  2005-08-26       Impact factor: 15.336

3.  Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate.

Authors:  M K Rosen; R F Standaert; A Galat; M Nakatsuka; S L Schreiber
Journal:  Science       Date:  1990-05-18       Impact factor: 47.728

4.  Total synthesis of rapamycin.

Authors:  Matthew L Maddess; Miles N Tackett; Hidenori Watanabe; Paul E Brennan; Christopher D Spilling; James S Scott; David P Osborn; Steven V Ley
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

5.  A Total Synthesis of FK-506(1).

Authors:  Robert E. Ireland; James L. Gleason; Laura D. Gegnas; Thomas K. Highsmith
Journal:  J Org Chem       Date:  1996-10-04       Impact factor: 4.354

6.  Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

Authors:  S N Sehgal; H Baker; C Vézina
Journal:  J Antibiot (Tokyo)       Date:  1975-10       Impact factor: 2.649

7.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors:  J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

8.  A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.

Authors:  M W Harding; A Galat; D E Uehling; S L Schreiber
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

9.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

10.  Inhibition of the immune response by rapamycin, a new antifungal antibiotic.

Authors:  R R Martel; J Klicius; S Galet
Journal:  Can J Physiol Pharmacol       Date:  1977-02       Impact factor: 2.273

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.